Study probes how lungs handle salt in rare bronchial condition
NCT ID NCT02586883
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the lungs move chloride, sodium, and bicarbonate in 42 patients with idiopathic bronchiectasis (widened airways of unknown cause). Researchers measured electrical signals in the airway lining during bronchoscopy and took nasal and bronchial samples. The goal was to identify specific transport abnormalities that might explain the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
42 people
The number who actually took part.
- Started
-
Mar 2016
- Finished
-
Nov 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
2 to 20 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Common criteria for all patients * Age between 2 and 20 years. * Patient weighing more than 12kg * Patients with a scheduled bronchoscopy under clinical monitoring (assessment of bronchial involvement, local samples for bacteriological and histological examination) * Signature of consent by the patient or by the / the holder (s) of parental authority and the investigator * Patient affiliated to a social security scheme or entitled * Patient with contraception (for woman of childbearing age) Specific criteria for idiopathic bronchiectasis patients Patient with idiopathic bronchiectasis in at least two lobes, diagnosis made after extensive screening of known acquired or congenital causes Specific criteria for "control" patients without abnormal ion transport * Patient Not having bronchiectasis s or any supposed alteration in transepithelial ion transport * Patients with fiberoptic bronchoscopy performed for one of the following indications: * Pulmonary malformations * Laryngeal, tracheal, bronchomalacia * Airway compression * Interstitial pathology * Suspicion of foreign body * Suspected tuberculosis Specific criteria for patients with a typical form of cystic f ibrosis (CF) Patient carrying 2 causing mutations in the CFTR gene (according to CFTR2 database; http://www.cftr2.org/mutations\_history.php) and sweat test\> 60 milliequivalent per liter (mEq/L). Exclusion Criteria: Common criteria for all patients * Smoking passive or active * Not essential bronchial endoscopy in the clinical follow * Extension of bronchoscopy time attributed to the difference in potential bronchial incompatible with the patient's general status * Patient pregnant or breast feeding * Hypersensitivity or cons known contraindications to health products for measurement of DDP (isoproterenol, Amiloride, ATP) Specific criteria for idiopathic DDB patients Presence of other congenital or acquired etiologies of DDB: * Typical or atypical cystic fibrosis, * Immunodeficiency, * Primary ciliary dyskinesia, * Abnormal bronchial wall structure (Williams-Campbell syndrome, Mounier-Kuhn, Ehlers-Danlos syndrome, Marfan's disease) * Infectious DDBs post * Extrinsic or endobronchial obstruction (foreign body, malformation, middle lobe syndrome) * Chronic inhalation (GERD, swallowing disorders, gastroesophageal tracheal fistula) * Allergic bronchopulmonary aspergillosis, * System disease.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cystic fibrosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necker-Enfants Malades Hospital
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Device-Preserved donor lungs boost transplant success?
- Can a simple questionnaire reveal why some cystic fibrosis patients skip physiotherapy?
- Cystic fibrosis diabetes: do gut hormones and genes hold the key?
- Can a special lung scan catch cystic fibrosis damage earlier than standard tests?
- Can a pill replace the liquid? testing a new form of cystic fibrosis drug
- Triple therapy under the microscope: does it transform cystic fibrosis care?